ProCE Banner Activity

Advancing Care and Improving Survival for Patients With HER2-Positive Breast Cancer

Slideset

Get up to date on the APP’s evolving role in caring for patients with HER2-positive breast cancer, including molecular testing, treatment selection, and managing treatment-related adverse events.

Released: April 21, 2023

Share

Faculty

Jeremy M. Force

Jeremy M. Force, DO

Assistant Professor
Department of Medicine
Division of Medical Oncology
Breast Oncology Program
Duke University
Durham, North Carolina

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

Supported by an educational grant from Seagen.

Seagen